Multiplikator forward rega marang pendapatan Supernus Corp (SUPN)
Supernus Pharmaceuticals (SUPN) relies on stable demand for ADHD and epilepsy medications. The forward price-to-sales ratio reflects the asset's dynamics, with the latest value recorded as 2.50. However, trade barriers and regulatory oversight create challenges for expansion. Meanwhile, a conservative approach to CNS development ensures the brand maintains pragmatic trust within the professional medical community.
Rincian metrik lan analitis perusahaan supernus.com (SUPN)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- rincian valuasi buku bisnis:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Supernus Pharmaceuticals|SUPN - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Supernus|SUPN - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Supernus Pharmaceuticals, Inc.|SUPN - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Supernus|Rasio cepet supernus.com
- data bathi bisnis lan rasio investasi:
SUPN - Penghasilan resik|Proyeksi bathi mangsa ngarep Supernus Pharmaceuticals|SUPN - Kapitalisasi marang bathi|Prakiraan rega marang bathi Supernus Corp|SUPN - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Supernus Corp|SUPN - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Supernus|SUPN - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan supernus.com|SUPN - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Supernus Pharmaceuticals
- informasi babagan volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:SUPN (Supernus Corp)
The forward P/S ratio reflects the market premium for expected revenue scalability by comparing current market capitalization with future sales volumes. For Supernus Pharmaceuticals (SUPN), this metric assesses the integration efficiency of acquired patents and the synergy of neuropharmaceutical alliances, allowing the forward P/S to differentiate fundamental business growth from speculative market volatility.
Pesaing Supernus Pharmaceuticals (SUPN)
Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Pharma|CPRX: Rega forward marang dodolan|Multiplikator Forward P/S DNLI|Rasio kapitalisasi marang dodolan sing dikarepake Harmony Biosciences|Biohaven Ltd - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Praxis Corp PRAX|AVXL: Multiplikator Forward P/S|CBLL (ceribell.com) - Rasio rega marang prakiraan pendapatan|PRTA (Prothena Corporation) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan alector.com (ALEC)|Rasio rega marang prakiraan pendapatan Annexon, Inc. (ANNX)|OMER - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Voyager Therapeutics Inc - Multiplikator Forward P/S|Neumora (NMRA) - Multiplikator forward rega marang pendapatan|SCLX: Multiplikator Forward P/S|TVGN - Rasio kapitalisasi marang dodolan sing dikarepake|ACOG (Alpha Cognition Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan cogrx.com (CGTX)|Rasio rega marang prakiraan pendapatan Inhibikase Therapeutics Inc (IKT)|Rasio kapitalisasi marang dodolan sing dikarepake Cassava Sciences|Multiplikator Forward P/S ASRT (Assertio Holdings)|COYA - Multiplikator forward rega marang pendapatan|vistagen.com - Multiplikator Forward P/S|OVID: Rasio rega marang prakiraan pendapatan|Acumen Pharmaceuticals, Inc (ABOS) - Rasio rega marang prakiraan pendapatan|CervoMed Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Alterity Therapeutics Limited|clene.com (CLNN) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PEPG (PepGen Inc)|Multiplikator Forward P/S jupiterneurosciences.com (JUNS)|Rasio rega marang prakiraan pendapatan Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalisasi marang prakiraan pendapatan|Grace Tx - Multiplikator Forward P/S|AIFF (Firefly Neuroscience Inc) - Kapitalisasi marang prakiraan pendapatan|KLTO: Multiplikator Forward P/S|NeuroSense Therapeutics, Ltd. (NRSN) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Reviva Pharmaceuticals, Inc.|Multiplikator forward rega marang pendapatan metaviatx.com (MTVA)|Multiplikator Forward P/S NRXS|HSDT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Passage Bio, Inc. - Multiplikator forward rega marang pendapatan|bionomics.com.au (NEUP) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Minerva - Multiplikator Forward P/S|Rega forward marang dodolan ATHA (Athira Pharma Inc)|ADXN: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|PTIX (Protagenic Therapeutics) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S KTTA|Rasio kapitalisasi marang dodolan sing dikarepake Cortigent|Multiplikator Forward P/S ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang prakiraan pendapatan|Cara Therapeutics Inc. - Multiplikator Forward P/S|Chromocell Therapeutics (CHRO) - Multiplikator forward rega marang pendapatan|ELYM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Multiplikator Forward P/S|Marinus - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S
